Medical Dialogues
  • Dermatology
Login Register
This site is intended for healthcare professionals only
Login Register
  • MD Brand Connect
  • Vaccine Hub
  • MDTV
    • Breaking News
    • Medical News Today
    • Health News Today
    • Latest
    • Journal Club
    • Medico Legal Update
    • Latest Webinars
    • MD Shorts
    • Health Dialogues
  • Fact Check
  • Health Dialogues
Medical Dialogues
  • Medical News & Guidelines
      • Anesthesiology
      • Cardiology and CTVS
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endocrinology
      • ENT
      • Gastroenterology
      • Medicine
      • Nephrology
      • Neurology
      • Obstretics-Gynaecology
      • Oncology
      • Ophthalmology
      • Orthopaedics
      • Pediatrics-Neonatology
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
      • Laboratory Medicine
      • Diet
      • Nursing
      • Paramedical
      • Physiotherapy
  • Health news
      • Doctor News
      • Government Policies
      • Hospital & Diagnostics
      • International Health News
      • Medical Organization News
      • Medico Legal News
      • NBE News
      • NMC News
  • Fact Check
      • Bone Health Fact Check
      • Brain Health Fact Check
      • Cancer Related Fact Check
      • Child Care Fact Check
      • Dental and oral health fact check
      • Diabetes and metabolic health fact check
      • Diet and Nutrition Fact Check
      • Eye and ENT Care Fact Check
      • Fitness fact check
      • Gut health fact check
      • Heart health fact check
      • Kidney health fact check
      • Medical education fact check
      • Men's health fact check
      • Respiratory fact check
      • Skin and hair care fact check
      • Vaccine and Immunization fact check
      • Women's health fact check
  • AYUSH
    • Ayurveda
    • Homeopathy
    • Siddha
    • Unani
    • Yoga
  • State News
      • Andaman and Nicobar Islands
      • Andhra Pradesh
      • Arunachal Pradesh
      • Assam
      • Bihar
      • Chandigarh
      • Chattisgarh
      • Dadra and Nagar Haveli
      • Daman and Diu
      • Delhi
      • Goa
      • Gujarat
      • Haryana
      • Himachal Pradesh
      • Jammu & Kashmir
      • Jharkhand
      • Karnataka
      • Kerala
      • Ladakh
      • Lakshadweep
      • Madhya Pradesh
      • Maharashtra
      • Manipur
      • Meghalaya
      • Mizoram
      • Nagaland
      • Odisha
      • Puducherry
      • Punjab
      • Rajasthan
      • Sikkim
      • Tamil Nadu
      • Telangana
      • Tripura
      • Uttar Pradesh
      • Uttrakhand
      • West Bengal
  • Medical Education
      • Ayush Education News
      • Dentistry Education News
      • Medical Admission News
      • Medical Colleges News
      • Medical Courses News
      • Medical Universities News
      • Nursing education News
      • Paramedical Education News
      • Study Abroad
  • Industry
      • Health Investment News
      • Health Startup News
      • Medical Devices News
      • Pharma News
      • Pharmacy Education News
      • Industry Perspective
  • MDTV
      • Health Dialogues MDTV
      • Health News today MDTV
      • Latest Videos MDTV
      • Latest Webinars MDTV
      • MD shorts MDTV
      • Medical News Today MDTV
      • Medico Legal Update MDTV
      • Top Videos MDTV
      • Health Perspectives MDTV
      • Journal Club MDTV
      • Medical Dialogues Show
This site is intended for healthcare professionals only
LoginRegister
Medical Dialogues
LoginRegister
  • Home
  • Medical news & Guidelines
    • Anesthesiology
    • Cardiology and CTVS
    • Critical Care
    • Dentistry
    • Dermatology
    • Diabetes and Endocrinology
    • ENT
    • Gastroenterology
    • Medicine
    • Nephrology
    • Neurology
    • Obstretics-Gynaecology
    • Oncology
    • Ophthalmology
    • Orthopaedics
    • Pediatrics-Neonatology
    • Psychiatry
    • Pulmonology
    • Radiology
    • Surgery
    • Urology
    • Laboratory Medicine
    • Diet
    • Nursing
    • Paramedical
    • Physiotherapy
  • Health news
    • Doctor News
    • Government Policies
    • Hospital & Diagnostics
    • International Health News
    • Medical Organization News
    • Medico Legal News
    • NBE News
    • NMC News
  • Fact Check
    • Bone Health Fact Check
    • Brain Health Fact Check
    • Cancer Related Fact Check
    • Child Care Fact Check
    • Dental and oral health fact check
    • Diabetes and metabolic health fact check
    • Diet and Nutrition Fact Check
    • Eye and ENT Care Fact Check
    • Fitness fact check
    • Gut health fact check
    • Heart health fact check
    • Kidney health fact check
    • Medical education fact check
    • Men's health fact check
    • Respiratory fact check
    • Skin and hair care fact check
    • Vaccine and Immunization fact check
    • Women's health fact check
  • AYUSH
    • Ayurveda
      • Ayurveda Giuidelines
      • Ayurveda News
    • Homeopathy
      • Homeopathy Guidelines
      • Homeopathy News
    • Siddha
      • Siddha Guidelines
      • Siddha News
    • Unani
      • Unani Guidelines
      • Unani News
    • Yoga
      • Yoga Guidelines
      • Yoga News
  • State News
    • Andaman and Nicobar Islands
    • Andhra Pradesh
    • Arunachal Pradesh
    • Assam
    • Bihar
    • Chandigarh
    • Chattisgarh
    • Dadra and Nagar Haveli
    • Daman and Diu
    • Delhi
    • Goa
    • Gujarat
    • Haryana
    • Himachal Pradesh
    • Jammu & Kashmir
    • Jharkhand
    • Karnataka
    • Kerala
    • Ladakh
    • Lakshadweep
    • Madhya Pradesh
    • Maharashtra
    • Manipur
    • Meghalaya
    • Mizoram
    • Nagaland
    • Odisha
    • Puducherry
    • Punjab
    • Rajasthan
    • Sikkim
    • Tamil Nadu
    • Telangana
    • Tripura
    • Uttar Pradesh
    • Uttrakhand
    • West Bengal
  • Medical Education
    • Ayush Education News
    • Dentistry Education News
    • Medical Admission News
    • Medical Colleges News
    • Medical Courses News
    • Medical Universities News
    • Nursing education News
    • Paramedical Education News
    • Study Abroad
  • Industry
    • Health Investment News
    • Health Startup News
    • Medical Devices News
    • Pharma News
      • CDSCO (Central Drugs Standard Control Organisation) News
    • Pharmacy Education News
    • Industry Perspective
  • Home
  • News
  • Industry
  • Pharma News
  • 22 drug samples fail...

22 drug samples fail to qualify CDSCO test, Details

Medical Dialogues TeamWritten by Medical Dialogues Team Published On 2021-12-23T17:31:06+05:30  |  Updated On 19 Oct 2023 4:01 PM IST
22 drug samples fail to qualify CDSCO test, Details
  • facebook
  • twitter
  • linkedin
  • whatsapp
  • Telegram
  • Email

New Delhi: In its latest drug safety alert, the apex drug regulatory body, Central Drugs Standard Control Organization (CDSCO) has flagged 22 medicine batches for failing to qualify for a random drug sample test for the month of November.

These drug samples include Eurokem Laboratories' Glimepiride Tablets, Bharat Parenterals' Phytomenadione Injectoin IP 10mg/ml (Vitamin K1 Injection) 1 ml, Zee Laboratories' LECETZY (Levocetirizine Tablets I.P.), Danish Health Care's Dixogyl-400 (Metronidazole Tablets IP 400 mg), Health Biotech's Lignocaine and Adrenaline Injection IP (ACAINE ADR INJECTION) and others.

This came after analysis and test were conducted by the CDSCO, Drugs Control Departments on 1102 samples. Out of this, 1080 samples were found of standard quality while 22 of them were declared as Not of Standard Quality (NSQ).

A few of the reasons why the drug samples tested failed were the failure of Sterility test, failure of dissolution test, failure of the assay, failure of moisture content test.

The samples collected were tested in five laboratories, namely CDL Kolkata, CDTL Mumbai, RDTL Chandigarh, CDTL Hyderabad.

List of Drugs, Medical Devices and Cosmetics declared as Not of Standard Quality/Spurious/Adulterated/Misbranded, for the Month of November – 2021

Total number of samples tested

1102

Total number of samples declared as of Standard Quality

1080

Total number of samples declared as Not of Standard Quality

22

Total number of samples declared as Spurious

-

Total number of samples declared as Misbranded

-


S.No.

Name of Drugs/medical device/cosmetics

Batch No./Date of Manufacture/Date of Expiry/Manufactured By

Reason for failure

Drawn By

From

1.

RL (Compound Sodium Lactate injection I.P. 500 ml) (Ringe Lactate Solution for Injection I.P.)

B. No.: 103111

Mfg dt: 03/2021 Exp dt: 02/2023

Mfd by: M/s. Ives Drugs (India) Pvt. Limited, Works: Ghatabillod, Distt. Dhar,

Madhya Pradesh.

Sterility

Drug Control Department Madhya Pradesh

CDL

Kolkata

2.

Glimepiride Tablets I.P. 1mg

B. No.: GP108 Mfg dt: 04/2021 Exp dt: 03/2023

Mfd by: M/s. Eurokem Laboratories Pvt. Ltd., C- 25, Sidco Pharmaceuticals Complex, Alathur, Thiruporur-603110 Tamil

Nadu.

Dissolution & Related Substances

CDSCO

South Zone Chennai

CDL

Kolkata

3.

Mineral Supplements Tablets

B. No.: ET-210101

Mfg dt: 01/2021 Exp dt: 12/2022

Mfd by: M/s. Ethicare Laboratories, 15, Industrial Estate, Digiana, Jammu- 180010.

Description

CDSCO

South Zone Chennai

CDL

Kolkata

4.

Vitamin B – Complex Tablets NFI III

B. No.: VPT801 Mfg dt: 06/2020 Exp dt: 11/2021

Mfd by: M/s. Unicure India Ltd., C- 21,22 & 23,

Sector-3, Noida 201301, Dist. Gautam Budh Nagar, Uttar Pradesh.

Description, Assay of Vitamin B1 & Calcium Pantothenate

CDSCO

South Zone Chennai

CDL

Kolkata


5.

Phytomenadione Injectoin IP 10mg/ml (Vitamin K1 Injection) 1 ml

B. No.: P0383

Mfg dt: 07/2020 Exp dt: 06/2022 Mfd by: M/s. Bharat

Parenterals Ltd., Vill, Haripura, Ta. Savli, Dist. Vadodara-391520,

Gujarat.

Description, Particulate Matter and Sterility

CDSCO

Hyderabad

CDL

Kolkata

6.

MULVIT (Multi Vitamin Tablets)

B. No.: CU20003

Mfg dt: 12/2020 Exp dt: 05/2022 Mfd by: M/s. Ortin

Laboratories Ltd., 275 &

278 (part), I.D.A.

Pashamilaram – 502307, Telangana.

Description, Identication of Vitamin D3, Assay of Vitamin A Acetate & Vitamin D3

CDSCO

East Zone Kolkata

CDL

Kolkata

7.

Telmopac – AM (Telmisartan

& Amlodipine Tablets)

B. No.: APT/04282

Mfg dt: 04/2021 Exp dt: 03/2023 Mfd by: M/s. Amkon

Pharmaceuticals, Plot No.

242, Ind. Area. Phase IX,

S.A.S. Nagar, Mohali – 160062(Punjab).

Dissolutoin, Related Substances and Assay

CDSCO

East Zone Kolkata

CDL

Kolkata

8.

Oflopac – OZ Tablet (Ofloxacin & Ornidazole Tablets I.P.)

B. No.: APT/03047

Mfg dt: 04/2020 Exp dt: 03/2022 Mfd by: M/s. Amkon

Pharmaceuticals, Plot No.

242, Phase – 9, Industrial

Area, Mohali- 160062 (Punjab).

Identification of Ofloxacin, and Dissolution & Assay of Ofloxacin & Ornidazole

CDSCO

East Zone Kolkata

CDL

Kolkata

9.

LECETZY

(Levocetirizine Tablets I.P.)

B. No.: 420-1286

Mfg dt: 10/2020 Exp dt: 09/2022 Mfd by: M/s. Zee

Laboratories, 47, Industrial

Area, Paonta Sahib- 173025, Himachal Pradesh.

Dissolution and Assay

CDSCO

East Zone Kolkata

CDL

Kolkata

10.

Ashialben 300

(Albendazole 300 mg Bolus)

B. No.: ALT-9096 Mfg dt: 08/2021 Exp dt: 07/2025 Mfd by: M/s. Ashish

Lifesciences Pvt. Ltd., J-

137, MIDC, Tarapur

Moisture content

CDSCO

West Zone Mumbai

CDTL

Mumbai

Maharashtra, India.

11.

Ashialben 300

(Albendazole 300 mg Bolus)

B. No.: ALT-8958

Mfg dt: 05/2021 Exp dt: 04/2025

Moisture content

CDSCO

West Zone Mumbai

CDTL

Mumbai

Mfd by: M/s. Ashish Lifesciences Pvt. Ltd., J- 137, MIDC, Tarapur, Maharashtra, India

12.

Ashialben 600 (Albendazole Bolus 600 mg)

B. No.: ALT-8703 Mfg dt: 12/2020

Exp dt: 11/2024

Moisture content

CDSCO

West Zone Mumbai

CDTL

Mumbai

Mfd by: M/s. Ashish Lifesciences Pvt. Ltd., J- 137, MIDC, Tarapur, Maharashtra, India.

13.

Ashialben 300

(Albendazole 300 mg Bolus)

B. No.: ALT-9090 Mfg dt: 08/2021

Exp dt: 07/2025

Moisture content

CDSCO

West Zone Mumbai

CDTL

Mumbai

Mfd by: M/s. Ashish Lifesciences Pvt. Ltd., J- 137, MIDC, Tarapur

Maharashtra, India.

14.

Dixogyl-400 (Metronidazole Tablets IP 400 mg)

B. No.: DLY2101

Mfg dt: 01/2021 Exp dt: 12/2022

Uniformity of weight

CDSCO

Sub Zone Indore

CDTL

Mumbai

Mfd by: M/s. Danish Health Care (P) Ltd., 76/27-28,

Industrial Estate, Maxi Road, Ujjan 456010, Madhya Pradesh.

15.

CLOPIDOGREL & ASPIRIN TABLETS IP (PILOGRELTM_ A75)

B. No.: ALA21002 Mfg dt: 02/2021 Exp dt: 01/2023

Mfd by: M/s. Psychotropics

India Ltd. Plot No. 46 & 49,

Description

CDSCO

Zonal Office Hyderabad

CDTL

Hyderabad

Sector-6A, IIE SIDCUL,

Ranipur, Haridwar-

249403, Uttarakhand.

16.

Diclofenac Sodium Prolonged Release Tablets IP (FENCO-100 SR)

B. No.: IDM20020 Mfg dt: 05/2020 Exp dt: 04/2023

Mfd by: M/s IBN Herbals,

{A unit of Curetech Formulations (P) Ltd.}, Khasra No. 63, Vill.- Juddi

Dissolution

Drug Control Department Kohima

RDTL

Guwahati


Kalan, Baddi, Dist.- Solan Himachal Pradesh.

17.

ATENOLOL AND AMLODIPINE TABLETS

B. No.: Z20-660

Mfg dt: 05/2020 Exp dt: 04/2022

Assay of Amlodipine

CDSCO

Sub-Zone Baddi

RDTL

Chandigarh

Mfd by: M/s. Zee Laboratories Ltd. Behind 47, Industrial Area, Paonta Sahib -173205, Himachal Pradesh.

18.

Lignocaine and Adrenaline Injection IP (A- CAINE ADR INJECTION)

B. No.: HILR2006F Mfg dt: 11/2020 Exp dt: 10/2022

Mfd by: M/s. Health Biotech Ltd. Village: Sandoli, Nalagarh Road, Baddi, Distt. Solan, Himachal Pradesh - 173205.

Assay of Adrenaline

Drug Control Department Himachal Pradesh

RDTL

Chandigarh

19.

Amlodipine Besylate and Atenolol Tablets (CARDINOL PLUS TABLETS)

B. No.: 1154-12

Mfg dt: 05/2021 Exp dt: 04/2024 Mfd by: M/s. Hab Pharmaceuticals &

Research Limited 10,

Pharmacity, SIDCUL, Selaqui, Dehradun- 248011, Uttarakhand.

Assay of Amlodipine

Drug Control Department Himachal Pradesh

RDTL

Chandigarh

20.

Atorvastatin Calcium Tablets IP 10 mg

B. No.: CATO009001 Mfg dt: 09/2020

Exp dt: 08/2022

Related Substances

CDSCO

Sub Zone Jammu

RDTL

Chandigarh

Mfd by: M/s. Celebrity Bipharma Ltd. Vill. Panga, Jharmajri, Hill Top Estate,

Barotiwala, Distt. Solan H.P. 174103.

21.

Ofloxacin and Metronidazole Suspension (OFLOX OZ SUSPENSION )

B. No.: CLOF1014 Mfg dt: 09/2021 Exp dt: 08/2023 Mfd by: M/s. CREST

LIFESCIENCES PVT.

Assay of Ofloxacin &

Metronidazole

CDSCO

Sub-Zone Baddi

RDTL

Chandigarh

LTD. Plot No. 127-128,

EPIP Phase-1, Jharmajri,

Tehsil Baddi, Dist. Solan,

Himachal Pradesh -

174103.

22.

NORFLOXACIN TABLETS IP

400 mg

B. No.: RJNL-17 Mfg dt: 06/2021 Exp dt: 05/2024

Mfd by: M/s. Combitic Global Caplet Pvt. Ltd., M- 15, D-2, D-3, Ind.Area,

Sonepat-131001, Haryana.

Dissolution

CDSCO

North Zone

RDTL

Chandigarh

To view the official notice, click the link below:

https://medicaldialogues.in/pdf_upload/drug-alert-listnov21-166656.pdf
drug alertglimepiridedixogyl-400phytomenadione injectioncdsconot of standard qualitydrug testAtorvastatinaspirinDiclofenacCLOPIDOGREL
Medical Dialogues Team
Medical Dialogues Team
    Show Full Article
    Next Story

    Editorial

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    Aspirin in Primary Prevention- When to Consider?

    Aspirin in Primary Prevention- When to Consider?

    Featured image representing medico legal

    What's the Role of Expert Opinion in Medical Negligence?

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    7- Point Discharge Protocol for AECOPD: Time to Inculcate in Practice

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    Aspirin Use in Women Aged 40-50 with Diabetes and Hypertension: Identifying the Ideal Candidates

    View All

    Journal Club Today

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Aditya Murali

    Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Breast Cancer...

    View All

    Health News Today

    Health Bulletin 09/ May/ 2025

    Health Bulletin 09/ May/ 2025

    View All
    © 2022 All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok